Diana E. Baxter

MiR-19b non-canonical binding is directed by HuR and confers chemosensitivity through regulation of P-glycoprotein in breast cancer

James L. Thorne, Sebastiano Battaglia, Diana E. Baxter et al. · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · 2018 · 40 citations

Medicine, Molecular Biology, Oncology +13

MiR-195 and Its Target SEMA6D Regulate Chemoresponse in Breast Cancer

Diana E. Baxter, Lisa M. Allinson, Waleed S. Al Amri et al. · Cancers · 2021 · 32 citations · Full text

Medicine, Cancer Biology, Oncology +17

Genomic and Expression Analyses Define MUC17 and PCNX1 as Predictors of Chemotherapy Response in Breast Cancer

Waleed S. Al Amri, Lisa M. Allinson, Diana E. Baxter et al. · Molecular Cancer Therapeutics · 2019 · 20 citations

Medicine, Molecular Genetics, Oncology +17

Identification of candidate mediators of chemoresponse in breast cancer through therapy-driven selection of somatic variants

Waleed S. Al Amri, Diana E. Baxter, Andrew M. Hanby et al. · Breast Cancer Research and Treatment · 2020 · 18 citations · Full text

Medicine, Cancer Biology, Oncology +14

Enzyme regulatory site-directed drugs. MOdulation of thymidine triphosphate inhibition of thymidine kinase by 5'-amino-5'-deoxythymidine.

Paul H. Fischer, Diana E. Baxter · Molecular Pharmacology · 1982 · 14 citations

Life Sciences, Biochemistry, Pharmacology +10